[Association between interleukin-1B polymorphisms and chronic obstructive pulmonary disease: a meta-analysis].
Jing-jing Mei1, Ying Liang, Ning Shen
1Department of Respiratory Medicine, Peking University Third Hospital, Beijing, China.
Zhonghua Yi Xue Za Zhi
|July 19, 2013
Summary
Interleukin-1B (IL-1B) gene polymorphisms are linked to chronic obstructive pulmonary disease (COPD) susceptibility in Caucasians. Specific IL-1B variants, -511C/T T allele and -31T/C C allele, show ethnicity-specific associations with COPD risk.
Area of Science:
- Genetics
- Immunology
- Pulmonary Medicine
Context:
- Chronic obstructive pulmonary disease (COPD) is a major global health issue.
- The role of genetic factors, specifically polymorphisms in inflammatory cytokine genes like interleukin-1B (IL-1B), in COPD susceptibility is under investigation.
Purpose:
- To conduct a meta-analysis exploring the association between specific interleukin-1B (IL-1B) gene polymorphisms (-511C/T, -31T/C, and +3954C/T) and the risk of developing chronic obstructive pulmonary disease (COPD).
Summary:
- A meta-analysis of seven case-control studies found no overall increased susceptibility to COPD associated with the studied IL-1B polymorphisms.
- However, subgroup analysis by ethnicity revealed significant associations in the Caucasian population: the -511C/T T allele increased COPD risk (OR = 1.76), and the -31T/C C allele decreased COPD risk (OR = 0.62).
- No significant associations were observed in the Asian population for any of the studied polymorphisms.
Impact:
- These findings suggest that IL-1B gene polymorphisms may influence COPD susceptibility in an ethnicity-specific manner.
- The results highlight the importance of considering genetic background in understanding COPD pathogenesis.
- Further research into the mechanisms underlying these ethnicity-specific genetic associations is warranted.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...